Silverfin false false 31/07/2024 31/07/2024 01/08/2023 no description of principal activity Mr James Robert Hendrie 14/07/2009 Mr John Wallace Hendrie 14/07/2009 SC362605 2024-07-31 SC362605 bus:Director1 2024-07-31 SC362605 bus:Director2 2024-07-31 SC362605 2023-07-31 SC362605 core:CurrentFinancialInstruments 2024-07-31 SC362605 core:CurrentFinancialInstruments 2023-07-31 SC362605 core:Non-currentFinancialInstruments 2024-07-31 SC362605 core:Non-currentFinancialInstruments 2023-07-31 SC362605 2023-08-01 2024-07-31 SC362605 bus:Micro-entities 2023-08-01 2024-07-31 SC362605 bus:FilletedAccounts 2023-08-01 2024-07-31 SC362605 bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 SC362605 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 SC362605 bus:Director1 2023-08-01 2024-07-31 SC362605 bus:Director2 2023-08-01 2024-07-31 SC362605 2022-08-01 2023-07-31 iso4217:GBP xbrli:pure

Company No: SC362605 (Scotland)

HENDRIE BIOTECH LIMITED

Unaudited Financial Statements
For the financial year ended 31 July 2024
Pages for filing with the registrar

HENDRIE BIOTECH LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 July 2024

Contents

HENDRIE BIOTECH LIMITED

BALANCE SHEET

As at 31 July 2024
HENDRIE BIOTECH LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 July 2024
Note 2024 2023
£ £
Fixed assets 646,513 663,360
Current assets 5 150,209 448,503
Prepayments and accrued income 7,222 10,223
Creditors: amounts falling due within one year 4 ( 165,452) ( 481,736)
Net current liabilities ( 8,021) ( 23,010)
Total assets less current liabilities 638,492 640,350
Creditors: amounts falling due after more than one year ( 435,492) ( 459,634)
Net assets 203,000 180,716
Capital and reserves 203,000 180,716

For the financial year ending 31 July 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hendrie Biotech Limited (registered number: SC362605) were approved and authorised for issue by the Board of Directors on 12 March 2025 and were signed on its behalf by:

Mr James Robert Hendrie
Director
Mr John Wallace Hendrie
Director
HENDRIE BIOTECH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 July 2024
HENDRIE BIOTECH LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 July 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC362605). The address of its registered office is West Overland Farm, Hurlford, Kilmarnock, KA1 5JY, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2

3. Guarantees and other financial commitments

Bank loans totalling £462,592 (2023 - £606,312) are secured by a guarantee and floating charge over the whole of the company's assets.

4. Related party transactions

Included within creditors is an amount owed to a company controlled by the directors of £78,000 (2023 - £280,000). This loan is interest free and has no fixed terms for repayment.

5. Transactions with directors

Included within current assets is an amount owed from the directors of £7,031 (2023 - £317,751). This loan is interest free and has no fixed terms for repayment.